Regulation of Assisted Reproductive Technologies: Gains and Losses

Indira Chakravarthi

Indian Journal of Gender Studies, 2016, vol. 23, issue 1, 133-156

Abstract: Technology assessment and regulatory strategies have been proffered as ways of addressing concerns and problems arising from availability of certain medical technologies. Regulation especially is invoked as a remedy that can deliver several objectives—as a way of assuring quality care; as a way of preventing medical malpractice and negligence; as a remedy for market failure; as a way of improving performance and efficiency; and as a way of even achieving national health objectives or wider social goals such as equity and accountability. It is assumed that the key issues in regulation are its design and having proper monitoring and enforcement.  The article reviews the regulations instituted to address issues arising from the use of reproductive technologies. Through such analysis, the article seeks to draw attention to the field of technology assessment and regulation in general as applicable to biomedical technologies, in a context of overall commercialisation of medical and health care.

Keywords: Fertility industry; gestational surrogacy; regulation of reproductive technologies; egg donor; reproductive choice (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0971521515612866 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:indgen:v:23:y:2016:i:1:p:133-156

DOI: 10.1177/0971521515612866

Access Statistics for this article

More articles in Indian Journal of Gender Studies from Centre for Women's Development Studies
Bibliographic data for series maintained by SAGE Publications ().